Related Content
Systematic Reviews on Drug Policy
The CDPE is synthesizing the evidence on the effectiveness of drug policies and interventions to reduce drug-related harms.
View
Drug Policy Metrics Map
The CDPE has conducted an international cross comparison of illegal drug policies to create an online tool – the Drug Policy Metrics Map – to demonstrate the alignment and gaps between the metrics that countries use to assess the success of their drug policy and the actual drug policy-related outcomes they experience.
View
#CannabisClaims
#CannabisClaims is a campaign addressing common misconceptions related to cannabis use and regulation.
View
A Roadmap for Cannabis Equity in Canada to Inform the Legislated Review of the Cannabis Act
This report analyzes the impact of the Cannabis Act on equity seeking groups and draws on best practices to develop a roadmap for cannabis equity in Canada, with the aim of informing the federal legislated review of the Cannabis Act.
View
Redressing Inequities in America’s Drug Policies: An Evidence-Grounded Call for Bold Action
In this brief for the Biden-Harris Administration, the CDPE and the Health in Justice Action Lab outline key actions to enhance the equity and effectiveness of drug policy in the United States.
View
How Diverse is Canada’s Legal Cannabis Industry? Examining Race and Gender of its Executives and Directors
The aim of this project was to examine the race and gender of c-suite level executives and boards of directors of licensed cannabis producers and their parent companies operating in the Canadian cannabis industry, in order to assess whether the promise of an equitable legal cannabis market has been achieved.
View
Impact Evaluations of Drug Decriminalisation and Legal Regulation on Drug Use, Health and Social Harms: A Systematic Review
Given increasing interest in quantifying the impact of drug law reform, as well as a lack of systematic assessment of outcomes beyond adolescent cannabis use to date, we conducted a systematic review of original peer-reviewed research evaluating the impacts of (a) legal regulation and (b) drug decriminalisation on drug availability, use or related health and social harms. Our primary aim is to characterise studies with respect to metrics and indicators used. The secondary aim is to summarise the findings and methodological quality of studies to date.
View
Canada’s Drug Futures Forum: Summary of Proceedings and Final Recommendations
This report synthesizes dialogue generated by speakers at the Canada’s Drug Futures Forum and outlines recommendations for the next ten years of Canadian drug policy from over 200 attendees including policymakers, public health officials, law enforcement professionals, researchers, people who use drugs, and community organizers.
View
Recreational Cannabis Regulation & International Law: Scenarios for States Parties to the UN Drug Conventions
This policy brief from the CDPE and the Munk School of Global Affairs at the University of Toronto provides guidance to national governments seeking to align domestic legalization and regulation of recreational cannabis markets with their international legal obligations.
View
New York NGO Committee on Drugs (NYNGOC)
The New York NGO Committee on Drugs (NYNGOC) provides a platform for discussion of drugs and drug-related subjects and interfaces with the United Nations to collaborate on solutions to global drug issues.
View